Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127074052 | 12707405 | 2 | F | 20160821 | 20160902 | 20160901 | 20160902 | PER | US-BAYER-2016-163882 | BAYER | 18.00 | YR | A | M | Y | 0.00000 | 20160902 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127074052 | 12707405 | 1 | PS | CLARITIN REDITABS | LORATADINE | 1 | Oral | 1 DF, QD | 20704 | 1 | DF | ORODISPERSIBLE TABLET | QD | ||||||
| 127074052 | 12707405 | 2 | SS | CLARITIN REDITABS | LORATADINE | 1 | Oral | 2 DF, ONCE | 20704 | 2 | DF | ORODISPERSIBLE TABLET | 1X |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127074052 | 12707405 | 1 | Multiple allergies |
| 127074052 | 12707405 | 2 | Multiple allergies |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127074052 | 12707405 | Drug ineffective | |
| 127074052 | 12707405 | Pain in extremity | |
| 127074052 | 12707405 | Product use issue | |
| 127074052 | 12707405 | Sneezing |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127074052 | 12707405 | 1 | 20160820 | 0 | ||
| 127074052 | 12707405 | 2 | 20160821 | 20160821 | 0 |